Comparison of Dynamic Distraction Systems in Proximal Interphalangeal Joint Fractures (DYNAFIX)

January 25, 2023 updated by: Waldfriede Hospital
Fractures of the proximal interphalangeal joints continue to pose significant management challenges. Thus the aim of our study is to compare two dynamic finger joint distractors (Litos® and Ligamentotaxor®) in respect to the radiological standard follow-up examination and functional assessments.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Berlin, Germany, 14163
        • Recruiting
        • Waldfriede Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

People who have sustained a proximal interphalangeal fracture treated with external dynamic fixator

Description

Inclusion Criteria:

  • proximal interphalangeal fracture treated with external dynamic fixator
  • Operative care <21 days from trauma
  • Age between 18 and 90 years.
  • Male and female

Exclusion Criteria:

- additional fractures or disabilities of the hand

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
LITOS
Patients who received a LITOS dynamic distraction system after 31.12.2017
Patients who received a LITOS dynamic distraction system after 31.12.2017
Ligamentotaxor
Patients who received a Ligamentotaxor dynamic distraction system after 31.12.2017
Patients who received a Ligamentotaxor dynamic distraction system after 31.12.2017

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disabilities of Arm, Shoulder and Hand (DASH) score
Time Frame: 3 months after explantation
Disabilities as measured by the DASH scale; No Difficulty (1), Mild Difficulty (2), Moderate Difficulty (3), Severe Difficulty (4), Unable (5)
3 months after explantation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analogue scale (VAS) pain
Time Frame: 3 months after explantation
From 0mm (no pain) to 100mm (maximum pain imaginable)
3 months after explantation
Functional assessment: Goniometry
Time Frame: 3 months after explantation
ROM of each joint of the injured fingert with a goniometer.
3 months after explantation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Markus Bock, MD, Waldfriede Hospital
  • Study Chair: Martin Lautenbach, MD, Waldfriede Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 14, 2020

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

June 30, 2024

Study Registration Dates

First Submitted

July 8, 2020

First Submitted That Met QC Criteria

July 8, 2020

First Posted (Actual)

July 14, 2020

Study Record Updates

Last Update Posted (Estimate)

January 26, 2023

Last Update Submitted That Met QC Criteria

January 25, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020.1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Interphalangeal Joint Fracture of the Hand

Clinical Trials on LITOS

Subscribe